Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XIENCE V/PROMUS Everolimus-Eluting Stent System Japan Post-marketing Surveillance Protocol

NCT01086228 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01086228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XIENCE V/PROMUS Everolimus-Eluting Stent System Japan Post-marketing Surveillance Protocol
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
August 31, 2016
Enrollment
2,010 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

angina, chronic coronary occlusion, coronary artery disease, coronary artery stenosis, coronary disease, coronary restenosis, myocardial ischemia, stent thrombosis, vascular disease